Immunotherapy for Advanced Hepatocellular Carcinoma-a Large Tertiary Center Experience
ConclusionIn our institutional experience, treatment naivety and pre-treatment AFP>400 ng/mL were associated with objective response. Prospective studies aimed at identifying factors associated with response to immunotherapy will aide patient selection.
Source: Journal of Gastrointestinal Surgery - Category: Surgery Source Type: research
More News: Avastin | Cancer | Cancer & Oncology | Carcinoma | Databases & Libraries | Gastroenterology | Hepatocellular Carcinoma | Immunotherapy | Liver | Liver Cancer | Study | Surgery | Urology & Nephrology